Cryo-Cell IntlCCEL
13F holders, Q4 2024 (December 31)20holders +6
4new positions
0sold out
$7.41avg. 13F price*
At the end of Q4 2024, 20 institutions reported holding Cryo-Cell Intl Inc. (CCEL) in their 13F filings, up 6 from Q3 2024. 4 opened new positions and 0 sold out. The largest holders were Hamilton Lane Advisors LLC ($3.0M), SFI Advisors, LLC ($1.2M) and Vanguard Group Inc. ($867K).
- Company
- Cryo-Cell Intl Inc.
- CUSIP
- 228895108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $457K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 82,073 shares bought and 18 shares sold, net +82,055 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Hamilton Lane Advisors LLC | 2.94% | No change | 409,734 | $3.0M |
| SFI Advisors, LLC | 0.86% | No change | 165,300 | $1.2M |
| Vanguard Group Inc. | 0.00% | Add +0.1% | 116,956 | $867K |
| MassMutual Private Wealth & Trust, FSB | 0.02% | No change | 111,035 | $823K |
| Topline Capital Management, LLC | 0.07% | — | 47,791 | $354K |
| Geode Capital Management, LLC | 0.00% | No change | 39,860 | $295K |
| Northern Trust Corp. | 0.00% | Add +78.2% | 38,902 | $288K |
| Heron Bay Capital Management | 0.05% | New | 31,766 | $235K |
| Cerity Partners LLC | 0.00% | No change | 19,563 | $145K |
| CreativeOne Wealth, LLC | 0.00% | New | 15,310 | $113K |
| Rowlandmiller & Partners.adv | 0.02% | New | 14,433 | $107K |
| BlackRock, Inc. | 0.00% | Reduce -0.1% | 13,639 | $101K |
| UBS Group AG | 0.00% | Add +1164.3% | 3,148 | $23K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +63.0% | 1,009 | $7K |
| Morgan Stanley | 0.00% | Add +0.2% | 601 | $4K |
| SBI Securities Co., Ltd. | 0.00% | — | 105 | $778 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 100 | $741 |
| Bank of America Corp. | 0.00% | No change | 33 | $245 |
| JPMorgan Chase & Co. | 0.00% | No change | 11 | $82 |
"% of holder's portfolio" is CCEL's weight in each manager's 13F, not the share of Cryo-Cell Intl Inc. the manager owns.